Dark

LGND
Ligand Pharmaceuticals Inc.
stock NASDAQ

Market Open

Apr 21, 2026 2:18:53 PM EDT

227.10USD-2.019%(-4.68)66,948

226.25Bid 261.34Ask 35.09Spread

Pre-market

0.00USD-100.000%(-231.78)0

After-hours

Apr 20, 2026 4:00:30 PM EDT

231.78USD-0.035%(-0.08)0

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

4.53B

CEO

John Higgins

Headquarters

San Diego, California, USA

Industry

Biotechnology

Next Earnings

May 14, 2026 (23d)

Last Dividend

Apr 3, 20072.500

Last Split

Nov 19, 20101for5.9999reverse

AMGN SPPI GSK BAX BMY JNJ LLY PFE MRK GTXI XLV

LGND Stats

Avg. Vol. 10 Day

245,320

Avg. Vol. 30 Day

251,189

Employees

Market Cap

4,525,165,357

Shares Out.

19,941,141

On/Off Exchange

60%/40%

6 Month Beta

0.85

1 Year Beta

0.93

2 Year Beta

1.00

3 Year Beta

0.98

52 Week Low

98.89

52 Week High

238.31

SMA50

202.56

SMA200

182.19

1 Week

-2.33%

1 Month

+10.80%

3 Month

+13.74%

6 Month

+21.57%

1 Year

+116.51%

2 Year

+231.13%

5 Year

+49.20%

Profile

ligand, a pharmaceutical company, is assembling a large and diverse portfolio of current and near-term commercial revenue generating assets to assist the long-term financial growth of the company. we operate this business on a lean cost structure that allows us to maximize cash flow and ultimately deliver a meaningful return for our shareholders.

LGND Stock Summary

Ligand Pharmaceuticals Inc. (NASDAQ:LGND) stock price today is $227.10, and today's volume is 66,948. LGND is down -2.019% today. The 30 day average volume is 251,189. LGND market cap is 4.53B with 19,941,141 shares outstanding.